share_log

Assertio Holdings And 2 Other Penny Stocks Insiders Are Buying

Assertio Holdings And 2 Other Penny Stocks Insiders Are Buying

Assertio Holdings和其他2只低价股票的内部人员正在购买
Benzinga ·  06/13 09:10

The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道琼斯指数周三收低约0.1%。当内部人士购买或卖出股票时,这表明他们对公司前景的信心或担忧。对于有兴趣投资或交易便士股的投资者和交易商而言,这是他们整体投资或交易决策中的一个因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是几个近期关于低价股的值得关注的内部交易。了解更多,请查看Benzinga内幕交易平台。

Kronos Bio

kronos bio

  • The Trade: Kronos Bio, Inc. (NASDAQ:KRON) President and CEO Norbert W Bischofberger bought a total of 3,005,122 shares at an average price of $1.04. To acquire these shares, it cost around $3.12 million.
  • What's Happening: On May 21, Kronos Bio named Deborah Knobelman as COO and CFO.
  • What Kronos Bio Does: Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription.
  • 交易:纳斯达克kronos bio股票代码为KRON的总裁兼CEO Norbert W Bischofberger以平均价1.04美元购买了305万122股。花费大约312万美元才能获得这些股票。
  • 近况:5月21日,kronos bio任命Deborah Knobelman为首席运营官和首席财务官。
  • kronos bio致力于发现和开发新型癌症治疗方案,通过定向调节失调的转录来实现精准医疗计划,以改变患者的治疗效果。

Assertio Holdings

assertio

  • The Trade: Assertio Holdings, Inc. (NASDAQ:ASRT) Director Jeff L Vacirca acquired a total of 10,000 shares at an average price of $1.11. To acquire these shares, it cost around $11,100.
  • What's Happening: On June 6, Assertio Holdings reported inducement grants under NASDAQ Listing Rule 5635(c)(4).
  • What Assertio Holdings Does: Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines.
  • 交易:纳斯达克assertio holdings股票代码为ASRT的董事Jeff L Vacirca以平均价1.11美元购买了1万股。花费约11100美元才能获得这些股票。
  • 正在发生的事情:6月6日,Assertio Holdings根据纳斯达克上市规则5635(c)(4)报告了引诱性授予。
  • Assertio Holdings Inc是一家药品公司。它致力于在神经学、孤儿和特殊药品领域提供解决方案,以推进患者护理。

Nanophase Technologies

Nanophase Technologies

  • The Trade: Nanophase Technologies Corporation (OTC:NANX) Director R Janet Whitmore acquired a total of 18,369 shares at an average price of $1.44. The insider spent around $26,487 to buy those shares.
  • What's Happening: On April 23, Nanophase Technologies announced financial results for the first quarter ended March 31, 2024.
  • What Nanophase Technologies Does: Nanophase Technologies Corp is engaged in the production of engineered nanomaterial solutions and larger, sub-micron, materials such as personal care sunscreens, architectural coatings, industrial coating applications, and abrasion-resistant additives, plastics additives, medical diagnostics, energy.
  • 交易:场外交易股票代码为NANX的Nanophase Technologies Corporation的董事R Janet Whitmore以平均价1.44美元购买了18369股,总花费约为26487美元。
  • 近况:4月23日,Nanophase Technologies宣布了2024年3月31日结束的第一季度的财务业绩。
  • Nanophase Technologies Corp专注于生产工程纳米材料解决方案和更大型的次微米材料,例如个人护理防晒霜、建筑涂料、工业涂料应用、耐磨添加剂、塑料添加剂、医疗诊断和能源等。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发